{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:25:08Z","timestamp":1790558708509,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Cape Town"},{"name":"DSI-NRF"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: Increasing the solid-state landscape of an active pharmaceutical ingredient (API) by generating new crystalline forms (e.g., polymorphs, cyclodextrin (CD) inclusion complexes, co-crystals, and salts) can yield products with significantly enhanced biopharmaceutical properties (especially increased water solubility), thereby improving API delivery and extending its lifetime. The aim of this study was the isolation of new solid forms of the poorly water-soluble non-steroidal anti-inflammatory drug fenbufen (FBF), for which relatively few solid phases have been reported to date. Further motivation for the study is the recent finding that it has potential for repurposing to treat acute pancreatitis. Methods: Interventions for generating new solid forms of FBF included (a) polymorph screening with a variety of solvent media, (b) attempts to form solid inclusion complexes with the native cyclodextrins \u03b1-, \u03b2-, and \u03b3-CD using various preparative methods, and (c) co-crystallization with a series of coformers to produce co-crystals and\/or molecular salts. Results: No new polymorphic forms of FBF were identified, but screening with CDs resulted in isolation and characterization of a new solid inclusion complex with \u03b3-CD. However, co-crystallization of FBF with the water-soluble coformer isonicotinamide yielded two new products, namely a 1:1 co-crystal and an unusual multi-component ionic co-crystal, whose aqueous solubility indicated significant enhancement of FBF solubility. Conclusions: Due to its extremely low water solubility, FBF presented challenges during the study aimed at modifying its crystalline form. However, two new supramolecular forms, a co-crystal and an ionic co-crystal, were isolated, the latter phase having potential for further formulation owing to its significantly enhanced solubility.<\/jats:p>","DOI":"10.3390\/pharmaceutics17070842","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:46:12Z","timestamp":1751438772000},"page":"842","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Screening for Polymorphism, Cyclodextrin Complexation, and Co-Crystallization of the Non-Steroidal Anti-Inflammatory Drug Fenbufen: Isolation and Characterization of a Co-Crystal and an Ionic Co-Crystal of the API with a Common Coformer"],"prefix":"10.3390","volume":"17","author":[{"given":"Hannah M.","family":"Fr\u00f6sler","sequence":"first","affiliation":[{"name":"Centre for Supramolecular Chemistry Research, University of Cape Town, Rondebosch 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0079-0431","authenticated-orcid":false,"given":"Neo Refiloe","family":"Mancapa","sequence":"additional","affiliation":[{"name":"Centre for Supramolecular Chemistry Research, University of Cape Town, Rondebosch 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6791-3785","authenticated-orcid":false,"given":"Laura","family":"Catenacci","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-5761","authenticated-orcid":false,"given":"Milena","family":"Sorrenti","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9372","authenticated-orcid":false,"given":"Maria Cristina","family":"Bonferoni","sequence":"additional","affiliation":[{"name":"Department of Drug Sciences, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-2600","authenticated-orcid":false,"given":"Mino R.","family":"Caira","sequence":"additional","affiliation":[{"name":"Centre for Supramolecular Chemistry Research, University of Cape Town, Rondebosch 7701, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Bernstein, J. (2020). Polymorphism of pharmaceuticals. Polymorphism in Molecular Crystals, Oxford University Press.","DOI":"10.1093\/oso\/9780199655441.001.0001"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sarabia-Vallejo, \u00c1., del Mar Caja, M., Olives, A.I., Mart\u00edn, M.A., and Men\u00e9ndez, J.C. (2023). Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092345"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Poulson, B.J., Alsulami, Q.A., Sharfalddin, A., El Agammy, E.F., Mouffouk, F., Emwas, A.-H., Jaremko, L., and Jaremko, M. (2022). Cyclodextrins: Structural, Chemical, and Physical Properties, and Applications. Polysaccharides, 3.","DOI":"10.3390\/polysaccharides3010001"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10940","DOI":"10.1021\/cr500081p","article-title":"A History of Cyclodextrins","volume":"114","author":"Crini","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1021\/acs.chemrev.1c00987","article-title":"Crystal Engineering of Pharmaceutical Cocrystals in the Discovery and Development of Improved Drugs","volume":"122","author":"Bolla","year":"2022","journal-title":"Chem. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.apsb.2021.03.030","article-title":"Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications","volume":"11","author":"Guo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Thakuria, R., and Sarma, B. (2018). Drug-Drug and Drug-Nutraceutical Cocrystal\/Salt as Alternative Medicine for Combination Therapy: A Crystal Engineering Approach. Crystals, 8.","DOI":"10.3390\/cryst8020101"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.cgd.3c00199","article-title":"An Overview on Polymorph Preparation Methods of Active Pharmaceutical Ingredients","volume":"24","author":"Zhou","year":"2024","journal-title":"Cryst. Growth Des."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/acs.cgd.2c00960","article-title":"Recent Advances in Polymorph Discovery Methods of Organic Crystals","volume":"23","author":"Yao","year":"2023","journal-title":"Cryst. Growth Des."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chistyakov, D., and Sergeev, G. (2020). The Polymorphism of Drugs: New Approaches to the Synthesis of Nanostructured Polymorphs. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010034"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42004-020-00388-9","article-title":"Open questions in organic crystal polymorphism","volume":"3","author":"Feeder","year":"2020","journal-title":"Commun. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hilfiker, R. (2006). Polymorphism: In the Pharmaceutical Industry, Wiley-VCH.","DOI":"10.1002\/3527607889"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18759","DOI":"10.3390\/molecules201018759","article-title":"Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs","volume":"20","author":"Censi","year":"2015","journal-title":"Molecules"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dodziuk, H. (2006). Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications, Wiley-VCH Verlag GmbH & Co., KGaA.","DOI":"10.1002\/3527608982"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nicolaescu, O.E., Belu, I., Mocanu, A.G., Manda, V.C., R\u0103u, G., P\u00eervu, A.S., Ionescu, C., Ciulu-Costinescu, F., Popescu, M., and Cioc\u00eelteu, M.V. (2025). Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17030288"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Musuc, A.M. (2024). Cyclodextrins: Advances in Chemistry, Toxicology, and Multifaceted Applications. Molecules., 29.","DOI":"10.3390\/molecules29225319"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2015.01.058","article-title":"Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review","volume":"113","author":"Mura","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1039\/b616399h","article-title":"Cocrystal architecture and properties: Design and building of chiral and racemic structures by solid\u2013solid reactions","volume":"136","author":"Jones","year":"2007","journal-title":"Faraday Discuss"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/acs.cgd.0c01278","article-title":"Computational Screening of Multicomponent Solid Forms of 2-Aryl Propionate Class of NSAID, Zaltoprofen, and Their Experimental Variation","volume":"21","author":"Dash","year":"2021","journal-title":"Cryst. Growth Des."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Wathoni, N., Sari, W.A., Elamin, K.M., Mohammed, A.F.A., and Suharyani, I. (2022). A Review of Coformer Utilization in Multicomponent Crystal Formation. Molecules, 27.","DOI":"10.3390\/molecules27248693"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2017.07.001","article-title":"Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges","volume":"117","author":"Chierotti","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_22","first-page":"307","article-title":"Drug-drug cocrystals: Opportunities and challenges","volume":"16","author":"Wang","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_23","unstructured":"(2025, April 29). Chemical Book. Available online: https:\/\/www.chemicalbook.com\/ProductChemicalPropertiesCB2239125_EN.htm."},{"key":"ref_24","first-page":"CD007547","article-title":"Single dose oral fenbufen for acute postoperative pain in adults","volume":"2009","author":"Moore","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_25","unstructured":"(2025, April 29). DrugBank Online. Available online: https:\/\/go.drugbank.com\/drugs\/DB08981."},{"key":"ref_26","unstructured":"(2025, April 25). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/."},{"key":"ref_27","first-page":"171","article-title":"The Cambridge Structural Database","volume":"B72","author":"Groom","year":"2016","journal-title":"Acta Cryst."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135455","DOI":"10.1016\/j.molstruc.2023.135455","article-title":"The molecular salt of pyrimethamine and fenbufen for enhancing dissolubility via an assisted efficacy-increasing approach of dual-drug salt formation: A combined study including theory analysis and experiment validation","volume":"1284","author":"Shen","year":"2023","journal-title":"J. Mol. Struct."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Miranda, G.M., Ramos, E., Santos, V.O., Bessa, J.R., Teles, Y.C.F., Yahou\u00e9d\u00e9hou, S.C.M.A., Goncalves, M.S., and Ribeiro-Filho, J. (2021). Inclusion Complexes of Non-Steroidal Anti-Inflammatory Drugs with Cyclodextrins: A Systematic Review. Biomolecules, 11.","DOI":"10.3390\/biom11030361"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kraszni, M., \u00c1gh, F., Horv\u00e1th, D., Mirzahosseini, A., and Horv\u00e1th, P. (2023). Effect of Substitution Degree and Homogeneity on Cyclodextrin-Ligand Complex Stability: Comparison of Fenbufen and Fenoprofen Using CD and NMR Spectroscopy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087544"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.chembiol.2017.02.003","article-title":"Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors","volume":"16","author":"Smith","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"ref_32","first-page":"e110523216783","article-title":"Fenbufen Alleviates Severe Acute Pancreatitis by Suppressing Caspase-1\/Caspase-11-mediated Pyroptosis in Mice","volume":"17","author":"Shen","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: From visualization to analysis, design and prediction","volume":"53","author":"Macrae","year":"2020","journal-title":"J. Appl. Crystallogr."},{"key":"ref_34","unstructured":"Program Analysis (2013). Version 3.1 for Windows, Soft Imaging System GmbH, Digital Solutions for Imaging and Microscopy, Program Analysis."},{"key":"ref_35","unstructured":"(2025, May 05). TA Instruments, Universal Analysis 2000 for Windows. Version 4.7A, TA Instruments\u2014Waters LLC, New Castle, Delaware, \u00a9 1998\u20132009. Available online: https:\/\/www.pubcompare.ai\/product\/wSPhCZIBPBHhf-iFqyCY\/."},{"key":"ref_36","unstructured":"TA Instruments, TRIOS (2025, May 05). Version 4.1.0.31739, TA Instruments\u2014Waters LLC, New Castle, Delaware, \u00a9 2016. Available online: https:\/\/www.tainstruments.com\/support\/software-downloads-support\/downloads\/."},{"key":"ref_37","first-page":"371","article-title":"On the isostructurality of cyclodextrin inclusion complexes and its practical utility","volume":"46","author":"Caira","year":"2001","journal-title":"Rev. Roum. Chim."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/ph3030558","article-title":"NSAIDs and Acute Pancreatitis: A Systematic Review","volume":"3","author":"Pezzilli","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/jo0162484","article-title":"Recurrence of Carboxylic Acid\u2212Pyridine Supramolecular Synthon in the Crystal Structures of Some Pyrazinecarboxylic Acids","volume":"67","author":"Vishweshwar","year":"2002","journal-title":"J. Org. Chem"},{"key":"ref_40","unstructured":"(2025, April 25). Good Laboratory Practice Bioscience. Available online: https:\/\/www.glpbio.com\/fenbufen.html."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/7\/842\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:57Z","timestamp":1760032797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/7\/842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["pharmaceutics17070842"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17070842","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}